CD4 and ovarian cancer: Herein, we show for the first time that a higher fraction of TNFR2+ expressing T cell subsets, particularly on CD4+CD25hiFoxP3+ (Tregs) can also be induced de novo from healthy donor PBMCs conditioned with cell-free ovarian cancer ascites.